XML 25 R13.htm IDEA: XBRL DOCUMENT v3.20.2

CAPITAL STRUCTURE	9 Months Ended
	Sep. 30, 2020
CAPITAL STRUCTURE
NOTE 7 - CAPITAL STRUCTURE	Preferred Stock The Company is authorized to issue 100 million shares of preferred stock, which may be issued from time to time in one or more series authorized by the Board of Directors. As of September 30, 2020, no preferred shares have been issued. Common Stock The Company is authorized to issue 300 million shares of common stock. As of September 30, 2020, and December 31, 2019, the Company had 13,225,387 shares of our common stock issued and 12,840,059 shares outstanding, respectively. Purchase of Treasury Shares On February 18, 2019, the Company entered into a Stock Purchase Agreement (the “SPA”) with an institutional noteholder. The SPA provides for the Company’s purchase of 83,341 shares of the Company’s common stock at $3.00 per share or an aggregate of $250,023. Payment was scheduled over a five-month period, subject to acceleration, if the Company effects an eligible equity offering. As of December 31, 2019, the Company had made $250,023 in payments. As of the date of this filing, 26,221 shares have been transferred back to the Company and subsequently cancelled. An additional 57,120 have been transferred to the Company, have not yet been cancelled and are recorded in treasury. On July 31, 2020, the Company entered into a Stock Purchase Agreement (the “July SPA”) with a shareholder.  The July SPA provides for the Company’s purchase of 10,000 shares of the Company’s common stock at $4.00 per share or an aggregate of $40,000. As of September 30, 2020, the Company made $40,000 in payments and no shares have been transferred back. On August 31, 2020, the Company entered into two Stock Purchase Agreements (the “August SPAs”) with a shareholder.  The August SPAs provide for the Company’s purchase of an aggregate total of 10,000 shares of the Company’s common stock at $4.00 per share or an aggregate of $40,000. As of September 30, 2020, the Company made $40,000 in payments and no shares have been transferred back. Potentially Dilutive Securities No options, warrants or other potentially dilutive securities have been issued as of September 30, 2020.

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

+ Details

Name:	us-gaap_PartnersCapitalNotesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration